Navigation Links
Research Shows Way for Drug Therapy for Autism

Indian neuroscientists are part of an international team that has for the first time reversed symptoms of mental retardation and autism in mice, raising hopes of drug therapy for this disorder that affects one in 500 children.

Researchers at the National Centre for Biological Sciences (NCBS) and National Institute of Mental Health and Neuroscience (NIMHANS) in Bangalore have contributed to the breakthrough, reported this week's Proceedings of the National Academy of Sciences (US).

Scientists at the Massachusetts Institute of Technology (MIT) in the US and Seoul National University in South Korea are part of the team.

Autism is a developmental disorder characterised by varying degrees of deficiencies in communication skills and social interactions, along with restricted, repetitive and stereotyped patterns of behaviour.

A strain of mice, genetically engineered by the Nobel laureate Susumu Tonegawa and colleagues at MIT, were manipulated to model "fragile X syndrome (FXS)", the leading inherited cause of mental retardation and the most common genetic cause of autism.

"The condition, tied to a mutated gene in the X chromosome, causes mild learning disabilities to severe autism," researcher Sumantra Chatterji at NCBS told IANS. Presently, there is no effective treatment for FXS and other types of autism affecting all races and ethnic groups, he said.

"Our findings have identified a specific enzyme in the brain, called p21-activated kinase (PAK), as a potential target for drugs that may reverse many of the debilitating symptoms of FXS, and possibly autism, in children.

"The enzyme PAK affects the number, size and shape of connections between neurons in the brain," he said.

In the brain, these connections between neurons are formed by small protrusions called "spines", which are spread on branches of neurons called "dendrites". The numbers and shapes of dendrit ic spines are crucial for normal brain function.

FXS patients have higher numbers of dendritic spines in their brains, but each spine is longer and thinner than in normal individuals.

"Our analysis shows that inhibition of PAK activity reverses the structural abnormality of neuronal connections seen in FXS mice," said Shankaranarayana Rao of NIMHANS, who was part of the study.

In addition to structural problems, these abnormal connections between neurons transmit weaker electric signals in FXS mice.

"Strikingly, blocking PAK activity also helped restore electrical signalling between neurons in the brains of the FXS mice," Chatterji said.

Interestingly, the FXS mice also exhibit abnormal behavioural symptoms like hyperactivity, purposeless, repetitive movements and learning difficulties commonly seen in autistic patients.

These behavioural problems are also ameliorated in the FXS mice with reduced PAK activity, the Indian researchers said.

Chatterji pointed out that the cutting-edge genetic engineering techniques used by his collaborators at MIT created a unique situation where PAK activity was blocked only after the debilitating symptoms of FXS had already taken hold in the mice.

"That PAK inhibition can reverse pre-existing symptoms of FXS is very good news for future design of drugs for treating fragile X in kids," said Chatterji.

There are known chemical compounds that inhibit the activity of PAK. These compounds or new ones targeted at PAK may greatly facilitate future development of drugs against FXS, and possibly autism as well, he said.


'"/>




Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
Breaking Medicine Technology: